BFA
IRWD icon

BlackRock Fund Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

BlackRock Fund Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$98.7M Buy
7,703,700
+838,115
+12% +$10.6M 0.02% 1207
2016
Q3 		$91.3M Buy
6,865,585
+290,400
+4% +$3.39M 0.02% 1155
2016
Q2 		$72M Sell
6,575,185
-32,793
-0.5% -$320K 0.02% 1247
2016
Q1 		$60.5M Sell
6,607,978
-49,284
-0.7% -$406K 0.01% 1318
2015
Q4 		$64.6M Sell
6,657,262
-345,150
-5% -$3.34M 0.01% 1291
2015
Q3 		$61.1M Sell
7,002,412
-26,298
-0.4% -$245K 0.02% 1285
2015
Q2 		$71M Buy
7,028,710
+262,773
+4% +$3.05M 0.02% 1267
2015
Q1 		$90.7M Buy
6,765,937
+393,708
+6% +$5.17M 0.02% 1082
2014
Q4 		$81.8M Buy
6,372,229
+665,708
+12% +$7.62M 0.02% 1111
2014
Q3 		$61.9M Buy
5,706,521
+69,671
+1% +$798K 0.02% 1214
2014
Q2 		$72.4M Sell
5,636,850
-285,308
-5% -$3.1M 0.02% 1142
2014
Q1 		$61.1M Buy
5,922,158
+1,187,248
+25% +$13.3M 0.02% 1261
2013
Q4 		$46M Buy
4,734,910
+120,702
+3% +$1.08M 0.01% 1462
2013
Q3 		$45.8M Buy
4,614,208
+541,669
+13% +$5.31M 0.02% 1410
2013
Q2 		$33.9M Buy
+4,072,539
New +$49.4M 0.01% 1486

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock Fund Advisors's IRWD Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Ironwood Pharmaceuticals (IRWD) stake by 12% in Q4 2016, buying an estimated $10.6M and bringing the position to 7,703,700 shares worth $98.7M. The position accounts for 0.02% of the portfolio, ranked #1207.

BlackRock Fund Advisors first reported a position in IRWD in Q2 2013 and has held it in 15 quarters since. 163 funds tracked by Wall St. Rank hold IRWD as of Q4 2016.

  • BlackRock Fund Advisors held 7,703,700 shares of Ironwood Pharmaceuticals worth $98.7M as of Q4 2016.
  • BlackRock Fund Advisors bought 838,115 Ironwood Pharmaceuticals shares in Q4 2016, an estimated $10.6M.
  • Ironwood Pharmaceuticals made up 0.02% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1207 holding.
  • BlackRock Fund Advisors first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • 163 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.